ClinicalTrials.gg
Sign In
RecruitingNCT07568418SCiPUpdated May 5, 2026

Skin Conductance in Ventilated Preterms

An interventional study of Skin Conductance Measurement in Mechanical Ventilation, Pain and Skin to Skin Care, sponsored by Uppsala University Hospital. Recruiting at 1 site in Sweden. Open to participants aged 22 Weeks and older. Per ClinicalTrials.gov, last updated 2026-05-05.

Sponsored by Uppsala University Hospital · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Aug 2025, registered Apr 2026).
  • Started Aug 2025; still recruiting 1 year 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
22 Weeks and older
Sex
All
01

Study summary

The goal of this observational study is to learn more about the pain and stress experienced by newborn infants receiving mechanical ventilation (breathing through a machine).

The main questions it aims to answer are:

  • Do different ventilator settings (modi) cause different degrees of pain and stress?
  • Can skin conductance measurement be used to evaluate the pain and stress caused by mechanical ventilation in newborns?
  • Can skin-to-skin care alleviate the stress caused by mechanical ventilation?

Participants will be monitored according to clinical protocol with the addition of electrodes placed on the infant's foot, measuring changes in skin conductance.

02

Conditions studied

  • Mechanical Ventilation
  • Pain
  • Skin to Skin Care
  • Kangaroo Mother Care

Browse trials for

Keywords

  • Skin Conductance Measurement
  • Pain
  • Newborn
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 50 is below the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Uppsala University Hospital is the lead sponsor of 73 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Weeks and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Need for mechanical ventilation

Exclusion criteria

Exclusion Criteria:

  • Other distracting painful conditions
  • Facial malformation or neuromuscular disease, not allowing regular visual pain assessment
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Interventions

  • DeviceSkin Conductance Measurement

    Objectifying stress by measuring changes in skin conductance using electrodes placed on the infants' feet.

06

What researchers measure

Primary outcomes

  1. Changes in skin conductance

    Changes in skin conductance measured in micro Siemens

    Time frame: From the time on one ventilator setting to another, on average about two weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07568418
Lead sponsor
Uppsala University Hospital
Responsible party
Johanna Tidehag Walan (Medical Doctor, Uppsala University Hospital) — Principal investigator
First posted
May 5, 2026
Start date
Aug 8, 2025
Primary completion
May 30, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
May 5, 2026

Study contacts

Johanna T Walan, Student Researcher
Contact
johanna.walan@uu.se
+46704184255

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pain →

Other studies from this sponsor

Uppsala University Hospital

Start the discussion